Erratum to "Safety of zonisamide therapy: Prospective follow-up survey" (DOI:10.1016/j.seizure.2004.04.006)

Seizure

Volumn 16, Issue 1, 2007, Pages 87-93

  Ohtahara, Shunsuke ^a   Yamatogi, Yasuko ^a  

^a OKAYAMA UNIVERSITY   (Japan)

Author keywords

Adverse effects; Epilepsy; Japan; Safety; Zonisamide

Indexed keywords

ERRATUM; ERROR; PRIORITY JOURNAL;

ABNORMALITIES, DRUG-INDUCED; ADOLESCENT; ADULT; AGE FACTORS; AGED; ANTICONVULSANTS; CHILD; CHILD, PRESCHOOL; DRUG THERAPY, COMBINATION; EPILEPSY; FEMALE; FOLLOW-UP STUDIES; GASTROINTESTINAL DISEASES; HUMANS; INCIDENCE; INFANT; ISOXAZOLES; MALE; MENTAL DISORDERS; MIDDLE AGED; PRODUCT SURVEILLANCE, POSTMARKETING;

EID: 33845479236     PISSN: 10591311     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.seizure.2006.01.005     Document Type: Erratum

References (20)

1. Masuda Y., Ishizaki M., and Shimizu M. Zonisamide: pharmacology and clinical efficacy in epilepsy. CNS Drug Rev 4 (1998) 341-360
2. Leppik I.E. Zonisamide. Epilepsia 40 suppl 5 (1999) S23-S29
3. Oommen K.J., and Mathews S. Zonisamide: a new antiepileptic drug. Clin Neuropharmacol 22 (1999) 192-200
4. Peters D.H., and Sorkin E.M. Zonisamide: a review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in epilepsy. Drugs 45 (1993) 760-787
5. Leppik I.E., Willmore L.J., Homan R.W., et al. Efficacy and safety of zonisamide: results of a multicenter study. Epilepsy Res 14 (1993) 165-173
6. Suzuki Y., Nagai T., Ono J., et al. Zonisamide monotherapy in newly diagnosed infantile spasms. Epilepsia 38 (1997) 1035-1038
7. Yamatogi Y, Ohtahara S. Current topics of treatment. In: Ohtahara S, Roger J, editors. Proceedings of the International Symposium on New Trends in Pediatric Epileptology, Okayama, Japan, Okayama University Medical School, 1991, p. 136-48.
8. Ohtsuka Y, Yoshida H, Miyake S, et al. Induced microseizures. A clinical and electroencephalographic study. In: Akimoto H, Kazamatsuri H, Seino M, Ward A, editors. Advances in Epileptology: Proceedings of the XIIIth Epilepsy International Symposium, New York, Raven Press, 1982, p. 33-5.
9. Berent S., Sackellares J.C., Giordani B., Wagner J.G., Donofrio P.D., and Abou-Khalil B. Zonisamide (CI-912) and cognition: results from preliminary study. Epilepsia 28 (1987) 61-67
10. Matsuura M., and Trimble M.R. Zonisamide and psychosis. J Epilepsy 10 (1997) 52-54
11. Miyamoto T., Kohsaka M., and Koyama T. Psychotic episodes during zonisamide treatment. Seizure 9 (2000) 65-70
12. Mayahara K., Kanemoto K., Kawasaki J., Nakagawa Y., Nishikawa S., and Kawai I. Zonisamide and episodic psychosis. J Jpn Epilepsy Soc 13 (1995) 177-183 (in Japanese)
13. Kimura S. Zonisamide-induced behavior disorders in two children. Epilepsia 35 (1994) 403-405
14. Okumura A., Hayakawa F., Kuno K., and Watanabe K. Oligohidrosis caused by zonisamide. No To Hattatsu (Tokyo) 28 (1996) 44-47 (in Japanese)
15. Hosoda N., Miura H., Shirai H., Sunaoshi W., and Takei K. Hypohidrosis by zonisamide. Jpn J Ped 49 (1996) 2445-2449 (in Japanese)
16. Takasaki E., and Maeda K. A population study of urolithiasis: incidence of urinary stone sufferers in a company. Jpn J Urol 66 (1975) 15-18 (in Japanese)
17. Kubota M., Nishi-Nagase M., Sakakihara Y., et al. Zonisamide-induced urinary lithiasis in patients with intractable epilepsy. Brain Dev 22 (2000) 230-233
18. Kondo T., Kaneko S., Amano Y., and Egawa I. Preliminary report on teratogenic effects of zonisamide in the offspring of treated women with epilepsy. Epilepsia 37 (1996) 1242-1244
19. Terada Y., Ichikawa H., Nishimura K., and Ohnishi K. Reproduction studies of zonisamide. Part 2. Teratogenicity study in rats. Jpn Pharmacol Ther 15 (1987) 4399-4416 (in Japanese)
20. Terada Y., Fukagawa S., Shigematsu K., Mukumoto K., Nishimura K., and Ohnishi K. Reproduction studies of zonisamide. Part 4. Teratogenicity study in mice, dogs and monkeys. Jpn Pharmacol Ther 15 (1987) 4435-4451 (in Japanese)